Cytarabine with high-dose mitoxantrone induces rapid complete remissions in adult acute lymphoblastic leukemia without the use of vincristine or prednisone

Journal of Clinical Oncology

Volumn 14, Issue 9, 1996, Pages 2480-2485

  Weiss, M ^a   Maslak, P ^a   Feldman, E ^a   Berman, E ^a   Bertino, J ^a   Gee, T ^a   Megherian, L ^a   Seiter, K ^a   Scheinberg, D ^a   Golde, D ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; MITOXANTRONE; PREDNISONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AGED; ARTICLE; CANCER REGRESSION; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HOSPITALIZATION; HUMAN; LEUKOCYTE COUNT; MALE; PRIORITY JOURNAL; SEPSIS; SURVIVAL TIME;

EID: 9544243672     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.9.2480     Document Type: Article

References (20)

1. Larson RA, Dodge RK, Burns CP, et al: A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: Cancer and leukemia group B study 8811. Blood 85: 2025-2037, 1995
2. Kantarjian HM, Walters RS, Keating MJ, et al: Results of the vincristine, doxorubicin, and dexamethasone regimen in adults with standard- and high-risk acute lymphocytic leukemia. J Clin Oncol 8:994-1004, 1990
3. Linker CA, Levitt LJ, O'Donnell M, et al: Treatment of adult acute lymphoblastic leukemia with intensive cyclical chemotherapy: A follow-up report. Blood 78:2814-2822, 1991
4. Schauer P, Arlin ZA, Mertelsmann R, et al: Treatment of acute lymphoblastic leukemia in adults: Results of the L-10 and L-10M protocols. J Clin Oncol 1:462-470, 1983
5. Hussein KK, Dahlberg S, Head D, et al: Treatment of acute lymphoblastic leukemia in adults with intensive induction, consolidation, and maintenance chemotherapy. Blood 73:57-63, 1989
6. Hoelzer DF: Therapy of the newly diagnosed adult with acute lymphoblastic leukemia. Hematol Oncol Clin North Am 7:139-160, 1993
7. Ellison RR, Mick R, Cuttner J, et al: The effects of postinduction intensification treatment with cytarabine and daunorubicin in adult acute lymphocytic leukemia: A prospective randomized clinical trial by Cancer and Leukemia Group B. J Clin Oncol 9:2002-2015, 1991
8. Willemze R, Peters WG, Colly LP: Short-term intensive treatment (VAAP) of adult acute lymphoblastic leukemia and lymphoblastic lymphoma. Eur J Haematol 41:489-495, 1988
9. Fiere D, Extra JM, David B, et al: Treatment of 218 adult acute lymphoblastic leukemias. Semin Oncol 14:64-66, 1987
10. Gottlieb AJ, Weinbert V, Ellison RR, et al: Efficacy of daunorubicin in the therapy of adult acute lymphocytic leukemia: A prospective randomized trial by Cancer and Leukemia Group B. Blood 64:267-274, 1984
11. Proctor SJ: Acute lymphoblastic leukaemia in adults: The case for a strategic shift in study approach. Br J Haem 88:229-233, 1994
12. Ohno R: Current progress in the treatment of adult acute leukemia in Japan. Jpn J Clin Oncol 22:85-97, 1993
13. Gaynor J, Chapman D, Little C, et al: A cause-specific hazard rate analysis of prognostic factors among 199 adults with acute lymphoblastic leukemia: The Memorial Hospital experience since 1969. J Clin Oncol 6:1014-1030, 1988
14. Hoelzer D, Thiel E, Loffler, et al: Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults. Blood 71:123-131, 1988
15. Feldman EJ, Alberts DS, Arlin Z, et al: Phase 1 clinical and pharmacokinetic evaluation of high-dose mitoxantrone in combination with cytarabine in patients with acute leukemia. J Clin Oncol 11:2002-2009, 1993
16. Esterhay Jr RJ, Wiernik PH, Grove WR, et al: Moderate dose methotrexate. vincristine, asparaginase, and dexamethasone for treatment of adult acute lymphocytic leukemia. Blood 59:334-345, 1982
17. National Cancer Institute, Division of Cancer Treatment: Common Toxicity Criteria. National Cancer Institute, Bethesda, MD, 1988
18. Clarkson B, Gaynor J, Little C. et al: Clinical trials in adults with acute lymphoblastic leukemia at Memorial Sloan-Kettering Cancer Center, in Gale R, Hoelzer D (eds): Acute Lymphoblastic Leukemia. New York, NY, Alan R. Liss, 1990, pp 231-252
19. Damon LE, Rugo HS, Ries CA, et al: Post-remission cytopenias following intense induction chemotherapy for acute myeloid leukemia. Leukemia 8:535-541, 1994
20. Ottman OG, Hoelzer D, Gracien E, et al: Concomitant granulocyte colony-stimulating factor and induction chemotherapy in adult acute lymphoblastic leukemia: A randomized phase 111 trial. Blood 88:444-450, 1995